Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-30 Purchase |
2021-03-31 7:11 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
359,375 | $16 | $5,750,000 | 13,359,456 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 6:50 pm |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
1,666,666 | $18 | $29,999,988 | 883,418 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 4:47 pm |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
1,285,714 | $3.5 | $4,499,999 | 8,053,298 (Indirect) |
View |
| 2020-12-28 Sale |
2020-12-30 4:38 pm |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director 10% Owner |
600,000 | $14.25 | $8,550,000 | 3,070,955 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:43 pm |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) |
View |
| 2020-09-25 Purchase |
2020-09-29 4:38 pm |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
950,000 | $18 | $17,100,000 | 475,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-02 Option Award |
2021-06-09 5:41 pm |
N/A 2031-06-01 |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
16,333 | $0 | 16,333 (Direct) |
View |
| 2021-03-30 Conversion |
2021-03-31 7:11 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
25,732,796 | $0 | 13,359,456 (Indirect) |
View |
Ownership |
2021-03-25 9:40 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
0 | $0 | 13,319,680 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 6:50 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
20,654,719 | $0 | 883,418 (Indirect) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:50 pm |
N/A 2031-02-10 |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2021-02-11 9:10 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
0 | $0 | 3,278,526 (Indirect) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:05 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner |
13,822,463 | $0 | 0 (Indirect) |
View |
| 2021-01-04 Option Award |
2021-01-05 7:00 pm |
N/A 2031-01-03 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director 10% Owner |
7,650 | $0 | 7,650 (Direct) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:43 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
33,046,445 | $0 | 1,221,700 (Indirect) |
View |
| 2020-12-03 Option Award |
2020-12-07 8:02 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
38,270 | $0 | 38,270 (Direct) |
View |
Ownership |
2020-12-03 8:59 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
0 | $0 | 7,550,411 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:38 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
6,114,330 | $0 | 475,000 (Indirect) |
View |
Ownership |
2020-09-24 7:17 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
0 | $0 | 6,114,330 (Indirect) |
View |
| 2020-06-17 Option Award |
2020-06-19 6:40 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-12 5:15 pm |
N/A 2030-06-09 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,782,584 (Direct) |
View |